PCPhillipo L. Chalya

Phillipo L. Chalya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phillipo L. Chalya has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of neural tube defects and their associated factors in Sub-Saharan Africa: a systematic review

    by Desmond M. Katunzi, Debora F. Samila, Michael Magoha, Henry D. Humba, Phillipo L. Chalya, Bipin Chaurasia

    Background Neural tube defects (NTDs) are critical birth deformities affecting the central nervous system, causing high morbidity and mortality in sub-Saharan Africa (SSA). This systematic review assesses their prevalence and contributing factors in SSA. Methods Following PRISMA guidelines, databases such as PubMed, Google Scholar, Cochrane Library, AJOL, EMBASE, and Science Direct were searched on January 7, 2025 with additional reference articles and gray literature. Studies published in English from 2010 to 2024 were included. Results Out of 763 articles, 22 met inclusion criteria. The overall prevalence of NTDs in SSA was 69.8 per 10,000 births (95% CI (confidence interval), 52.8–94.3). Spina bifida had the highest prevalence at 19.43 per 10,000 births (95% CI, 13.76–21.55), anencephaly at 5.77 per 10,000 births (95% CI, 3.22–9.44), and encephalocele at 1.27 per 10,000 births (95% CI, 1.03–3.11). Significant factors associated with NTDs included lack of folic acid supplementation (AOR: 0.42; 95% CI, 0.13–0.98), maternal age > 30 (AOR—Adjusted odds ratio, 2.11; 95% CI, 1.31–7.78), newborn sex (AOR, 3.42; 95% CI, 2.53–8.77), consanguineous marriage (AOR, 2.42; 95% CI, 1.22–8.68), pesticide exposure (AOR, 3.12; 95% CI, 2.33–8.41), maternal alcohol consumption (AOR, 2.42; 95% CI, 1.13–4.98), previous NTD history, radiation exposure (AOR, 2.21; 95% CI, 1.13–3.91), maternal fever (AOR, 3.22; 95% CI, 2.16–5.32), and previous stillbirth history (AOR, 2.55; 95% CI, 2.16–4.11). Conclusion NTDs remain prevalent in SSA, with many avoidable factors. Folic acid fortification and supplementation for reproductive-age women could significantly reduce the burden of NTDs.


  • Open Access

    Incidence, predictors and early outcomes of acute kidney injury among patients undergoing abdominal surgery at Bugando Medical Centre, Mwanza, Tanzania

    by Rashid Said, Samuel Byabato, Vihar Kotecha, Leonard Washington, Ladius Rudovick, Evarist Msati, Phillipo Chalya

    Background: Acute kidney injury (AKI) is a frequent occurrence following major surgery and is independently associated with high morbidity and mortality. Data regarding AKI following abdominal surgery is limited in the sub-Saharan Africa and Tanzania in particular. This study aimed to determine the incidence, predictors and early outcome of AKI among patients undergoing abdominal surgery at Bugando Medical Centre (BMC). Methods: This was a longitudinal study to determine the incidence, predictors and early outcome of acute kidney injury among patients undergoing abdominal surgery at BMC between March 2022 and July 2022. Results: A total of 172 patients were studied (M: F= 1.1: 1). The overall median age of patients at presentation was 34 years. Forty-six (26.7%) patients developed AKI postoperatively. Among the patients who had AKI, 30(65.2%) were classified as KDIGO stage1, 12 (20.1%) as stage 2 and 4 (8.7%) as stage 3. On multivariate analysis, the age ≥45 years (p=0.036), pre-existing medical illness (p=0.015), pre-existing renal dysfunction (p= 0.007), duration of surgery (p=0.007) and emergency surgery (p= 0.001) were the main predictors of postoperative AKI. The overall median length of hospital was 8.7 days and the overall mortality rate was 5.8%. The mortality rate among patients with AKI was significantly high compared to patients without AKI (15.2% v/s 2.4%; p= 0.020). Postoperative AKI was independently significantly associated with prolonged length of hospital stay (p= 0.001) and mortality (p=0.020). Recovery was observed in 63% of patients who developed post-operative AKI. Conclusion: AKI incidence is high among patients undergoing abdominal surgery at BMC and is associated with high mortality and increased LOS. Prompt identification and aggressive treatment of postoperative AKI risk factors offer the potential of reducing the burden of AKI in this group of patients.

  • Open Access

    Clinical profile, treatment modalities and outcomes among patients with upper aero-digestive tract emergencies at Bugando Medical Centre, Mwanza, Tanzania

    by Cecilia Protas, Olivia Kimaro, Alex Donasiano, Samson K. Ephraim, Phillipo L. Chalya

    Background: Upper aero-digestive tract emergencies (UADTEs) are common in our setting and can be life-threatening and challenging to otolaryngologists. However, there is a paucity of clinical studies on these emergencies. This study aimed to determine the clinical profile, treatment modalities and outcomes of upper aero-digestive tract emergencies at Bugando Medical Centre (BMC), Mwanza, Tanzania. Methods: Between January and May 2019, a cross-sectional study involving patients presenting with a clinical diagnosis of UADTEs was conducted at BMC. Results: Of 487 ENT emergencies seen during the study period, 128 (26.3%) patients had UADTEs. Males outnumbered females by a ratio of 1.5: 1. Their median age at presentation was 5 [range, 2-40] years. The major causes of UADTEs were foreign body ingestion, head and neck tumours, foreign body aspiration and cut-throat injuries that were seen in 56(43.8%), 33(25.8%), 25(19.5%) and (3.9%), respectively. The most frequent presentations were dysphagia 81(63.3%), difficulty in breathing 61(47.7%) and odynophagia 56(43.8). Age ≤ 40 years (p=0.02), prolonged duration to treatment (p=0.04) and low blood oxygen saturation (SPO2) (p=0.04) were significantly associated with poor outcomes following esophagoscopy. In addition, delayed duration to treatment (p=0.01) and foreign body ingestion (p=0.001) were significantly associated with prolonged hospital stay. Conclusion: UADTEs are common at BMC and constitute a significant cause of otorhinolaryngological admission with foreign bodies in the aerodigestive tract as the most typical cause of these emergencies. Most of these injuries can be prevented through public enlightenment campaigns. Early detection and management of UADTEs is essential to reduce morbidity and mortality associated with these emergencies.


  • Open Access

    Indications for and complications of intestinal stomas in the children and adults at a tertiary care hospital in a resource-limited setting: a Tanzanian experience

    by Alicia Massenga, Alfred Chibwae, Aloyce A. Nuri, Merchades Bugimbi, Yasin K. Munisi, Ramadhani Mfinanga, Phillipo L. Chalya

    An intestinal stoma, though a life-saving procedure on the care of many gastrointestinal conditions, carries significant number of complications. This study describes the common indications, complications, and management of stomas and identifies the factors that are associated with these complications in a tertiary care hospital in Tanzania. A cross-sectional study of patients with intestinal stomas was conducted at Bugando Medical Centre (BMC) between July 2016 and June 2017. Ethical approval to conduct the study was obtained from relevant authority before the commencement of the study. A total of 167 patients (M: F = 1.2:1) were enrolled in the study. The mean age at diagnosis was 0.6 ± 1.4 years for children and mean age for adults was 36.7 ± 15.8 years. Anorectal malformation (110, 89.4%) was the most common indication for intestinal stoma formation in children, while bowel perforation (14, 31.8%) was the main indications in adults. The sigmoid colon (137, 82.0%) was the most common anatomical site for stoma formation followed by the ileum (18, 10.8%). Stoma prolapse (18, 41.9%) was the most frequent complication of a stoma, whereas, surgical site infection (9, 34.6%) was the most frequent complication after stoma closure. Thirty five (26.7.%) of the children developed stomal complications, while only 8 (22.2%) of the adults developed complications. The level of training of operating surgeon and timing of surgery were the main predictors of stoma-related complications (p < 0.034 and 0.013), whereas the level of training of the operating surgeon and the type of stoma closure were significantly associated with the complications related to stoma closure (p < 0.001). The intestinal stomas performed at BMC are associated with various complications, which in turn, become a burden to the patients. The insights observed in the current study may apply to other tertiary hospitals in Tanzania and Africa at large. We suggest that the keystones for improvement and control in the formation and complications of intestinal stomas are the following; colostomy formation should rarely be done in transverse colon, the procedure should be carried out by senior doctors (specialist) or junior doctors under close and direct supervision of the specialists, using proper meticulous techniques, and the need to determine and/or improve techniques for early detection of complications.


  • Open Access

    Treatment outcome of anti-angiogenesis through VEGF-pathway in the management of gastric cancer: a systematic review of phase II and III clinical trials

    by Brian Mawalla, Xianglin Yuan, Xiaoxiao Luo, Phillip L. Chalya

    Advanced gastric cancer poses a therapeutic challenge worldwide. In randomised clinical trials, anti-VEGF has been reported as an essential agent for the treatment of advanced gastric cancer. This review aims at assessing the treatment outcome of anti-angiogenesis therapy through the VEGF pathway in the management of patients with advanced gastric cancer. During this review, 38 clinical trials were identified. Of these, 30 clinical trials were excluded, leaving eight trials of phase II and III. Ramucirumab, as a second line treatment of advanced gastric cancer, decreases the risk of disease progression (37–52%) and death (19–22%). Compare ramucirumab and bevacizumab in combination with traditional chemotherapy; ramucirumab has shown to improve progression-free survival and overall survival. Apatinib tyrosine kinase inhibitor combined with traditional chemotherapy has shown to improve overall response rate and progression-free survival with marginal improvements in overall survival. Chemotherapy, in combination with anti-VEGF drugs, in the management of advanced gastric cancer significantly improves the outcome of overall response rate, progression-free survival and overall survival when compared to chemotherapy alone. Therefore, we recommend that anti-VEGF drugs are the drugs of choice in the management of patients with advanced gastric cancer.